Get started
Author

Mark Matson

Observed names: M. Matson, M.A. Matson, Mark A Matson, Mark A. Matson
ORCID: 0009-0000-4058-7211
Observed ORCID: 0009-0000-4058-7211
OpenAlex ID: A5021367289
Effects of AMG 145 on Low-Density Lipoprotein Cholesterol Levels
2012 · Clapton S. Dias, Adam J. Shaywitz, et al. · Journal of the American College of Cardiology · 233
PDF
TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study
2021 · Ciarán P. Kelly, Joseph A. Murray, et al. · Gastroenterology · 211
Pharmacokinetics and Pharmacodynamics of MK‐5046, a Bombesin Receptor Subtype‐3 (BRS‐3) Agonist, in Healthy Patients
2011 · Marc L. Reitman, Victor Dishy, et al. · The Journal of Clinical Pharmacology · 44
Pharmacokinetics and Safety of FV-100, a Novel Oral Anti-Herpes Zoster Nucleoside Analogue, Administered in Single and Multiple Doses to Healthy Young Adult and Elderly Adult Volunteers
2011 · Helen S. Pentikis, Mark Matson, et al. · Antimicrobial Agents and Chemotherapy · 38
Long-term Follow-up of 369 Diabetic Patients Undergoing Dialysis
1988 · M. Matson · Archives of Internal Medicine · 36
Pharmacokinetics, Pharmacodynamics, and Safety of ASP015K (Peficitinib), a New Janus Kinase Inhibitor, in Healthy Subjects
2016 · Ying Jun Cao, Taiji Sawamoto, et al. · Clinical Pharmacology in Drug Development · 30
Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: a comparative phase 2/3 trial
2019 · Mark A. Matson, Eran Schenker, et al. · Human Vaccines & Immunotherapeutics · 14
Immune Pharmacodynamic Responses of the Novel Cancer Immunotherapeutic Imprime PGG in Healthy Volunteers
2019 · Nandita Bose, Nadine R Ottoson, et al. · The Journal of Immunology · 14
Pharmacokinetics, pharmacodynamics, and safety of peginterferon beta‐1a in subjects with normal or impaired renal function
2014 · Xiao Hu, Ali Seddighzadeh, et al. · The Journal of Clinical Pharmacology · 12
PDF
A short 2 week dose titration regimen reduces the severity of flu-like symptoms with initial interferon gamma-1b treatment
2014 · John G. Devane, Mary L. Martin, et al. · Current Medical Research and Opinion · 12
PDF
460 a Study of the Safety and Pharmacokinetics of Single Ascending Oral Doses of Inx-08189, a Nucleotide Polymerase Inhibitor, in Healthy Subjects
2011 · J. Patti, M. Matson, et al. · Journal of Hepatology · 12
PDF
Dose titration of intramuscular interferon beta-1a reduces the severity and incidence of flu-like symptoms during treatment initiation
2011 · Mark A. Matson, Thomas R. Zimmerman, et al. · Current Medical Research and Opinion · 10
First-in-Human Phase I Clinical Trial of the Adenosine A1R/A3R Agonist AST-004 in Healthy Subjects
2024 · Lisa M. Manna, Juan Hernandez, et al. · Stroke · 8
Abstract 10701: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability and Pharmacodynamics of AMG145
2011 · Clapton Dias, Adam J. Shaywitz, et al. · Circulation · 8
Immune characteristics correlating with HSV‐1 immune control and effect of squaric acid dibutyl ester on immune characteristics of subjects with frequent herpes labialis episodes
2019 · Hugh McTavish, Katherine W. Zerebiec, et al. · Immunity Inflammation and Disease · 7
PDF
Demand for and Changing Patient Population, Mortality, and Death Patterns in Chronic Dialysis
1987 · C. M. Kjellstrand, M. Matson · Springer eBooks · 7
AMG 145, a Fully Human Monoclonal Antibody Against PCSK9, Reduces LDL-C in Healthy Volunteers and Patients on Stable Doses of Statins†
2012 · Adam J. Shaywitz, Clapton Dias, et al. · Journal of clinical lipidology · 3
AB0364 Pharmacokinetics, safety, and tolerability of asp015k, a novel janus kinase inhibitor, in healthy volunteers
2013 · T. Zhu, T. Sawamoto, et al. · Annals of the Rheumatic Diseases · 2
A Study of the Safety and Pharmacokinetics of Multiple Ascending Doses of FV-100 in Healthy Subjects
2009 · Mark Matson, Helen Pentikis, et al. · Antiviral Research · 2
Effect of hepatic impairment on the pharmacokinetics of ripretinib.
2022 · Xiaoyan Li, Charles M Psoinos, et al. · Journal of Clinical Oncology · 1
Effects of strong cytochrome P450 (CYP)3A4 inducers/inhibitors on the pharmacokinetic (PK) profile of anamorelin in healthy volunteers.
2018 · Elizabeth Duus, Mark A. Matson, et al. · Journal of Clinical Oncology · 1
Effect of imprime PGG on innate immune-activating pharmacodynamic changes in a phase I clinical study in healthy human volunteers.
2017 · Nandita Bose, Nadine Ottoson, et al. · Journal of Clinical Oncology · 1
A Study of the Safety and Pharmacokinetics of Single and Multiple Doses of FV-100 in Subjects 65 Years and Over
2009 · Mark Matson, George Atiee, et al. · Antiviral Research · 1
Abstract B008: Imprime PGG, an intravenously administered beta glucan PAMP activates the innate immune system: A phase I clinical study to evaluate immunopharmacodynamic responses
2016 · Nadine C. Ottoson, Richard D. Huhn, et al. · Cancer Immunology Research
Pharmacokinetics, Safety, and Tolerability of Peginterferon beta-1a Delivered by Single-Use Autoinjector and Pre-Filled Syringe (P01.163)
2013 · Xiao Hu, Shifang Liu, et al. · Neurology
Works count: 26
Citation count: 707
H-index: 11
I10-index: 12
Year
Topic
Type